New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Regulated (List II)Translated

NAFRONYL

200MG/Extended-release Film-coated Tablet/NAFTIDROFURYL HYDROGENO-OXALATE
BIOGALENIC
ManufacturerVerified lab

BIOGALENIC

Public retail price
N/ADZD

Identification

Active ingredient (INN)
NAFTIDROFURYL HYDROGENO-OXALATE
Internal code
06 J 101
Country of Origin
Algeria
Pharmaceutical form
Extended-release Film-coated Tablet
Prescription List
Regulated (List II)
Packaging
b/20
NAFRONYL
Clinical View
Regulated (List II)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Mechanism of Action

Mechanism of action

Naftidrofuryl has a 5 HT 2 blocker activity, is opposed to vasoconstrictive effects in animals and to the proagregant platelet effects of serotonin in animals and humans.

Adverse Effects

Rash Severe hepatitis Cytolytic hepatitis Oral ulceration Vomiting Diarrhoea Esophagitis Digestive disorder Epigastric pain Oxalic lithiasis.

Alternatives